Thomas Jefferson University
Clinical trials sponsored by Thomas Jefferson University, explained in plain language.
-
Heating tumors to boost cancer Drug's power
Disease control TerminatedThis small, early-stage study tested whether heating tumors on the chest wall could make the cancer drug olaparib work better for people with recurring breast cancer. The main goal was to find the safest dose of the drug when used with the heating treatment. The study was termina…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Can texting about fasting help fight brain cancer?
Disease control TerminatedThis study tested whether a mobile app that guides patients through a time-restricted eating schedule could help protect their memory and thinking skills and improve survival after radiation treatment for brain metastases. The trial was designed for adults with breast or lung can…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Faster, more precise radiation aims to tame prostate cancer
Disease control TerminatedThis study tested a new, shorter radiation schedule for men with high-risk prostate cancer. Using MRI guidance, doctors aimed to deliver stronger radiation doses more precisely to the prostate and nearby lymph nodes over fewer sessions. The main goal was to see if this faster app…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can a short video save lives? study aims to boost lung cancer screening in At-Risk communities
Knowledge-focused TerminatedThis study tested whether short, culturally tailored educational videos could help people in vulnerable communities learn about lung cancer and screening. Researchers worked with African American, Korean, and Chinese adults who were current or former smokers. The goal was to see …
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC